New

Saphenous Vein Grafts Market

2021

Saphenous Vein Grafts Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Application (Coronary Artery Bypass Grafting (CABG), AV Access, and Vascular Reconstruction); End Use (Hospitals, Ambulatory Surgical Centers, and Others), and Geography

| Report Code: TIPRE00025021 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Market Insights

Saphenous Vein Grafts Market 2028 By Application, End Use, and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

The saphenous vein is the biggest superficial vein in the leg and called internal, great, or greater saphenous vein. It starts from the merger of the dorsal vein of the great toe and the dorsal venous network of the foot. The vein ascends from the medial side for the lower leg and then runs the medial side of the anterior region to the thigh. After reaching the saphenous opening, the vein joins with the femoral vein. Saphenous vein grafts are primarily used for revascularization procedures and in coronary artery bypass surgery.

MARKET SCOPE

The "Global Saphenous Vein Grafts Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Saphenous vein grafts market with detailed market segmentation by application, end use, and geography. The report provides key statistics on the market status of the leading Saphenous vein grafts market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on application, the global Saphenous vein grafts market is segmented into coronary artery bypass grafting (cabg), av access, vascular reconstruction.
  •  On the basis of end use, the market is segmented into hospitals, ambulatory surgical centers, others.

MARKET DYNAMICS
Drivers:

  •  Rise in the adoption of cardiovascular procedure.
  •  Rise in the geriatric population.
  •  Growing occurrence of peripheral artery disease.

Restraints:

  •  The availability of alternate surgeries is the major restraining factor for this market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Saphenous vein grafts market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Saphenous vein grafts market in these regions.

IMPACT OF COVID-19 ON SAPHENOUS VEIN GRAFTS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Saphenous vein grafts market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Saphenous vein grafts market are anticipated to lucrative growth opportunities in the future with the rising demand for Saphenous vein grafts in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Saphenous vein grafts market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  CryoLife, Inc
  •  LifeNet Health
  •  LeMaitre Vascular, Inc.
  •  Abbott
  •  Boston Scientific Corporation
  •  Hancock Jaffe Laboratories, Inc.
  •  KARL STORZ SE & Co. KG
  •  Getinge AB
  •  Medtronic
  •  Terumo Cardiovascular Systems Corporation

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Saphenous Vein Grafts Market - By Application
1.3.2 Saphenous Vein Grafts Market - By End Use
1.3.3 Saphenous Vein Grafts Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SAPHENOUS VEIN GRAFTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SAPHENOUS VEIN GRAFTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SAPHENOUS VEIN GRAFTS MARKET - GLOBAL MARKET ANALYSIS
6.1. SAPHENOUS VEIN GRAFTS - GLOBAL MARKET OVERVIEW
6.2. SAPHENOUS VEIN GRAFTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. SAPHENOUS VEIN GRAFTS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. CORONARY ARTERY BYPASS GRAFTING (CABG)
7.3.1. Overview
7.3.2. Coronary Artery Bypass Grafting (CABG) Market Forecast and Analysis
7.4. AV ACCESS
7.4.1. Overview
7.4.2. AV Access Market Forecast and Analysis
7.5. VASCULAR RECONSTRUCTION
7.5.1. Overview
7.5.2. Vascular Reconstruction Market Forecast and Analysis
8. SAPHENOUS VEIN GRAFTS MARKET - REVENUE AND FORECASTS TO 2028 - END USE
8.1. OVERVIEW
8.2. END USE MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. AMBULATORY SURGICAL CENTERS
8.4.1. Overview
8.4.2. Ambulatory Surgical Centers Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. SAPHENOUS VEIN GRAFTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Saphenous Vein Grafts Market Overview
9.1.2 North America Saphenous Vein Grafts Market Forecasts and Analysis
9.1.3 North America Saphenous Vein Grafts Market Forecasts and Analysis - By Application
9.1.4 North America Saphenous Vein Grafts Market Forecasts and Analysis - By End Use
9.1.5 North America Saphenous Vein Grafts Market Forecasts and Analysis - By Countries
9.1.5.1 United States Saphenous Vein Grafts Market
9.1.5.1.1 United States Saphenous Vein Grafts Market by Application
9.1.5.1.2 United States Saphenous Vein Grafts Market by End Use
9.1.5.2 Canada Saphenous Vein Grafts Market
9.1.5.2.1 Canada Saphenous Vein Grafts Market by Application
9.1.5.2.2 Canada Saphenous Vein Grafts Market by End Use
9.1.5.3 Mexico Saphenous Vein Grafts Market
9.1.5.3.1 Mexico Saphenous Vein Grafts Market by Application
9.1.5.3.2 Mexico Saphenous Vein Grafts Market by End Use
9.2. EUROPE
9.2.1 Europe Saphenous Vein Grafts Market Overview
9.2.2 Europe Saphenous Vein Grafts Market Forecasts and Analysis
9.2.3 Europe Saphenous Vein Grafts Market Forecasts and Analysis - By Application
9.2.4 Europe Saphenous Vein Grafts Market Forecasts and Analysis - By End Use
9.2.5 Europe Saphenous Vein Grafts Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Saphenous Vein Grafts Market
9.2.5.1.1 Germany Saphenous Vein Grafts Market by Application
9.2.5.1.2 Germany Saphenous Vein Grafts Market by End Use
9.2.5.2 France Saphenous Vein Grafts Market
9.2.5.2.1 France Saphenous Vein Grafts Market by Application
9.2.5.2.2 France Saphenous Vein Grafts Market by End Use
9.2.5.3 Italy Saphenous Vein Grafts Market
9.2.5.3.1 Italy Saphenous Vein Grafts Market by Application
9.2.5.3.2 Italy Saphenous Vein Grafts Market by End Use
9.2.5.4 Spain Saphenous Vein Grafts Market
9.2.5.4.1 Spain Saphenous Vein Grafts Market by Application
9.2.5.4.2 Spain Saphenous Vein Grafts Market by End Use
9.2.5.5 United Kingdom Saphenous Vein Grafts Market
9.2.5.5.1 United Kingdom Saphenous Vein Grafts Market by Application
9.2.5.5.2 United Kingdom Saphenous Vein Grafts Market by End Use
9.2.5.6 Rest of Europe Saphenous Vein Grafts Market
9.2.5.6.1 Rest of Europe Saphenous Vein Grafts Market by Application
9.2.5.6.2 Rest of Europe Saphenous Vein Grafts Market by End Use
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Saphenous Vein Grafts Market Overview
9.3.2 Asia-Pacific Saphenous Vein Grafts Market Forecasts and Analysis
9.3.3 Asia-Pacific Saphenous Vein Grafts Market Forecasts and Analysis - By Application
9.3.4 Asia-Pacific Saphenous Vein Grafts Market Forecasts and Analysis - By End Use
9.3.5 Asia-Pacific Saphenous Vein Grafts Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Saphenous Vein Grafts Market
9.3.5.1.1 Australia Saphenous Vein Grafts Market by Application
9.3.5.1.2 Australia Saphenous Vein Grafts Market by End Use
9.3.5.2 China Saphenous Vein Grafts Market
9.3.5.2.1 China Saphenous Vein Grafts Market by Application
9.3.5.2.2 China Saphenous Vein Grafts Market by End Use
9.3.5.3 India Saphenous Vein Grafts Market
9.3.5.3.1 India Saphenous Vein Grafts Market by Application
9.3.5.3.2 India Saphenous Vein Grafts Market by End Use
9.3.5.4 Japan Saphenous Vein Grafts Market
9.3.5.4.1 Japan Saphenous Vein Grafts Market by Application
9.3.5.4.2 Japan Saphenous Vein Grafts Market by End Use
9.3.5.5 South Korea Saphenous Vein Grafts Market
9.3.5.5.1 South Korea Saphenous Vein Grafts Market by Application
9.3.5.5.2 South Korea Saphenous Vein Grafts Market by End Use
9.3.5.6 Rest of Asia-Pacific Saphenous Vein Grafts Market
9.3.5.6.1 Rest of Asia-Pacific Saphenous Vein Grafts Market by Application
9.3.5.6.2 Rest of Asia-Pacific Saphenous Vein Grafts Market by End Use
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Saphenous Vein Grafts Market Overview
9.4.2 Middle East and Africa Saphenous Vein Grafts Market Forecasts and Analysis
9.4.3 Middle East and Africa Saphenous Vein Grafts Market Forecasts and Analysis - By Application
9.4.4 Middle East and Africa Saphenous Vein Grafts Market Forecasts and Analysis - By End Use
9.4.5 Middle East and Africa Saphenous Vein Grafts Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Saphenous Vein Grafts Market
9.4.5.1.1 South Africa Saphenous Vein Grafts Market by Application
9.4.5.1.2 South Africa Saphenous Vein Grafts Market by End Use
9.4.5.2 Saudi Arabia Saphenous Vein Grafts Market
9.4.5.2.1 Saudi Arabia Saphenous Vein Grafts Market by Application
9.4.5.2.2 Saudi Arabia Saphenous Vein Grafts Market by End Use
9.4.5.3 U.A.E Saphenous Vein Grafts Market
9.4.5.3.1 U.A.E Saphenous Vein Grafts Market by Application
9.4.5.3.2 U.A.E Saphenous Vein Grafts Market by End Use
9.4.5.4 Rest of Middle East and Africa Saphenous Vein Grafts Market
9.4.5.4.1 Rest of Middle East and Africa Saphenous Vein Grafts Market by Application
9.4.5.4.2 Rest of Middle East and Africa Saphenous Vein Grafts Market by End Use
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Saphenous Vein Grafts Market Overview
9.5.2 South and Central America Saphenous Vein Grafts Market Forecasts and Analysis
9.5.3 South and Central America Saphenous Vein Grafts Market Forecasts and Analysis - By Application
9.5.4 South and Central America Saphenous Vein Grafts Market Forecasts and Analysis - By End Use
9.5.5 South and Central America Saphenous Vein Grafts Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Saphenous Vein Grafts Market
9.5.5.1.1 Brazil Saphenous Vein Grafts Market by Application
9.5.5.1.2 Brazil Saphenous Vein Grafts Market by End Use
9.5.5.2 Argentina Saphenous Vein Grafts Market
9.5.5.2.1 Argentina Saphenous Vein Grafts Market by Application
9.5.5.2.2 Argentina Saphenous Vein Grafts Market by End Use
9.5.5.3 Rest of South and Central America Saphenous Vein Grafts Market
9.5.5.3.1 Rest of South and Central America Saphenous Vein Grafts Market by Application
9.5.5.3.2 Rest of South and Central America Saphenous Vein Grafts Market by End Use
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SAPHENOUS VEIN GRAFTS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. SAPHENOUS VEIN GRAFTS MARKET, KEY COMPANY PROFILES
12.1. CRYOLIFE, INC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. LIFENET HEALTH
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. LEMAITRE VASCULAR, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ABBOTT
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BOSTON SCIENTIFIC CORPORATION
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. HANCOCK JAFFE LABORATORIES, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. KARL STORZ SE AND CO. KG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. GETINGE AB
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MEDTRONIC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. CryoLife, Inc
2. LifeNet Health
3. LeMaitre Vascular, Inc.
4. Abbott
5. Boston Scientific Corporation
6. Hancock Jaffe Laboratories, Inc.
7. KARL STORZ SE & Co. KG
8. Getinge AB
9. Medtronic
10. Terumo Cardiovascular Systems Corporation
11. Cigna
TIPRE00025021
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.